EP Patent

EP1760076A1 — FAP Inhibitors

Assigned to Ferring BV · Expires 2007-03-07 · 19y expired

What this patent protects

The present invention concerns compounds, according to general formula 1, which find utility, preferably for the treatment of cancer.

USPTO Abstract

The present invention concerns compounds, according to general formula 1, which find utility, preferably for the treatment of cancer.

Drugs covered by this patent

Patent Metadata

Patent number
EP1760076A1
Jurisdiction
EP
Classification
—
Expires
2007-03-07
Drug substance claim
No
Drug product claim
No
Assignee
Ferring BV
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.